EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Research Progress on the Application of Antidepressants in Breast Cancer Treatment

Zhanying Niu, Yiqi Wang, Min Li, Yucheng Li

Chinese medicine and natural products · 01.09.2026 · 06 (03) · e186-e193

DOI: 10.1055/a-2943-5227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chinese medicine and natural products, erschienen am 01.09.2026. Verfasst von Zhanying Niu und 3 weiteren Autor:innen. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depression frequently co-occurs with breast cancer in clinical practice, and the two conditions interact reciprocally to form a vicious cycle that accelerates disease progression. Traditional Chinese medicine (TCM) theory holds that liver qi stagnation intermingled with phlegm and blood stasis constitutes the shared pathogenesis of breast cancer and depression. Accumulating studies have demonstrated that various antidepressants not only alleviate emotional disorders in breast cancer patients but also exert synergistic anti-breast cancer effects through multiple mechanisms, as well as effectively alleviate adverse reactions induced by antitumor therapies. This paper systematically reviews domestic and international research progress, summarizes the clinical application value and action mechanisms of commonly used antidepressants in breast cancer management, and analyzes their clinical advantages and limitations. Meanwhile, it summarizes the dual antidepressant and antitumor efficacy of liver-soothing and depression-relieving formulas represented by Xiaoyao San, together with natural active components such as baicalin and curcumin. This review aims to provide theoretical references and novel perspectives for integrated traditional Chinese and Western medicine comprehensive intervention, optimization of targeted combination therapy strategies, and research and development of novel adjuvant therapeutic agents for patients with comorbid breast cancer and depression.

Zitieren

APA

Niu, Z., Wang, Y., Li, M., & Li, Y. (2026). Research Progress on the Application of Antidepressants in Breast Cancer Treatment. Chinese medicine and natural products, 06(03), e186-e193. https://doi.org/10.1055/a-2943-5227

Vancouver

Niu Z, Wang Y, Li M, Li Y. Research Progress on the Application of Antidepressants in Breast Cancer Treatment. Chinese medicine and natural products. 2026;06(03):e186-e193. doi:10.1055/a-2943-5227

BibTeX
@article{Niu2026,
  author = {Niu, Zhanying and Wang, Yiqi and Li, Min and Li, Yucheng},
  title = {Research Progress on the Application of Antidepressants in Breast Cancer Treatment},
  journal = {Chinese medicine and natural products},
  year = {2026},
  volume = {06},
  number = {03},
  pages = {e186--e193},
  doi = {10.1055/a-2943-5227}
}
Kostenlos starten →